Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Matthew Li Kam Wa"'
Autor:
Kaier, Thomas E., Harriet Hurrell, Tiffany Patterson, Matthew Li Kam Wa, Gracie Fisk, Jack Stewart, Kamran Baig, Michael Ghosh-Dastidar, Young, Christopher P., Simon Redwood, Kalpa De Silva, Brian Clapp, Divaka Perera, Pavlidis, Antonis N.
Publikováno v:
King's College London
Guidelines endorse a heart team (HT) approach to standardize the decision-making process for patients with complex coronary artery disease (CAD). With percutaneous treatment options for complex CAD increasing, we hypothesized that practice had change
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6338cd68c9ed0bbc7dc21008d0849ba8
https://pubmed.ncbi.nlm.nih.gov/35916923
https://pubmed.ncbi.nlm.nih.gov/35916923
Publikováno v:
Medicine. 50:467-468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6554ec904ec9353b209b2bc0361d0fe
https://doi.org/10.1016/j.mpmed.2022.04.014
https://doi.org/10.1016/j.mpmed.2022.04.014
Autor:
Nicholas McWilliams, Deacon Lee, Mark Whitfield, Matthew Li Kam Wa, Katherine Dickinson, Reshma Amin, Alex Khouri, Robert Gerber, David Walker
Publikováno v:
Interventional Cardiology.
Introduction The optimum treatment strategy for patients who undergo PCI but also require anticoagulation remains undetermined. There have been a handful of studies to date that suggest altered doses of rivaroxaban may lead to reduced bleeding, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96dec9339cdb8aa2d31fc52b9d9a1752
https://doi.org/10.1136/heartjnl-2018-bcs.60
https://doi.org/10.1136/heartjnl-2018-bcs.60